focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Share News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.00
Bid: 44.00
Ask: 46.00
Change: 0.50 (1.12%)
Spread: 2.00 (4.545%)
Open: 44.50
High: 45.00
Low: 44.50
Prev. Close: 44.50
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cambridge Cognition Strikes Reseller Agreement With AnthroTronix

Thu, 02nd Jun 2016 07:26

LONDON (Alliance News) - Neuroscience technology company Cambridge Cognition Holdings PLC on Thursday said it has signed a reseller deal with US engineering research and development firm AnthroTronix Inc.

The deal will cover DANA, the brain health assessment product provided by AnthroTronix, which measures and monitors subtle and acute changes in cognitive efficiency.

Cambridge Cognition will get the rights to distribute the DANA software to European military organisations and occupational health providers under the deal.

No financial details were disclosed.

"We are delighted to have agreed this reseller agreement with AnthroTronix. Having worked informally with AnthroTronix since 2015 we are confident that DANA fits within our existing point-of-care product portfolio and are excited by the opportunity to commercialise the product through established Cambridge Cognition sales channels to new and existing customers, particularly European militaries and occupational health organisations," said Cambridge Cognition Chief Executive Steven Powell.

Cambridge Cognition shares were untraded early Thursday at 38.00 pence.

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
8 Apr 2021 11:24

AIM WINNERS & LOSERS: Minds + Machines up on USD120 million asset sale

AIM WINNERS & LOSERS: Minds + Machines up on USD120 million asset sale

Read more
30 Mar 2021 16:03

IN BRIEF: Cambridge Cognition wins contract for schizophrenia trial

IN BRIEF: Cambridge Cognition wins contract for schizophrenia trial

Read more
30 Mar 2021 13:56

Cambridge Cognition wins fourth schizophrenia trial contract

(Sharecast News) - Cambridge Cognition has won a £1.3m contract as the cognitive assessment partner for a schizophrenia trial, it announced on Tuesday.

Read more
23 Mar 2021 11:58

Cambridge Cognition shares surge as it eyes profitability in 2021

Cambridge Cognition shares surge as it eyes profitability in 2021

Read more
16 Mar 2021 15:53

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
19 Jan 2021 13:45

Cambridge Cognition Sees "Significant" Revenue Growth During 2020

Cambridge Cognition Sees "Significant" Revenue Growth During 2020

Read more
21 Dec 2020 14:20

IN BRIEF: Cambridge Cognition Wins GBP700,000 Digital Health Contract

IN BRIEF: Cambridge Cognition Wins GBP700,000 Digital Health Contract

Read more
7 Oct 2020 18:20

UK TRADING UPDATE SUMMARY: Gym Group Fighting Fit With Fresh York Unit

UK TRADING UPDATE SUMMARY: Gym Group Fighting Fit With Fresh York Unit

Read more
22 Sep 2020 14:12

UK EARNINGS SUMMARY: IGas Swings Sharply To Loss As Revenue Halves

UK EARNINGS SUMMARY: IGas Swings Sharply To Loss As Revenue Halves

Read more
15 Sep 2020 15:53

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
14 Sep 2020 13:13

IN BRIEF: Cambridge Cognition Hires Diurnal CFO Bungay As Non-Exec

IN BRIEF: Cambridge Cognition Hires Diurnal CFO Bungay As Non-Exec

Read more
1 Sep 2020 16:22

Cambridge Cognition wins £2m contract with pharma firm

(Sharecast News) - Brain health company Cambridge Cognition has won a £2m contract as the cognitive assessment partner for three late-phase clinical trials for a pharmaceutical company's lead drug candidate for patients with schizophrenia, it announced on Tuesday.

Read more
1 Sep 2020 11:57

Cambridge Cognition Secures GBP2 Million Deal For Schizophrenia Trials

Cambridge Cognition Secures GBP2 Million Deal For Schizophrenia Trials

Read more
27 Jul 2020 17:58

UK EXECUTIVE CHANGE SUMMARY: Provident Financial Taps Former MP James

UK EXECUTIVE CHANGE SUMMARY: Provident Financial Taps Former MP James

Read more
20 Jul 2020 15:53

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.